Niranib is an anti-cancer targeted therapy medication used for chemotherapy. Niranib is used for the treatment of ovarian, fallopian tube or primary peritoneal cancer.
How it Works
Niranib works as targeted therapy where it is highly selective for PARP1 and PARP2 which work to detect DNA damage and promote repair. Niranib inhibits the activity of PARP1 and PARP2 which results in cancerous cell death.
Common Side effects
Some of the common side effects that may arise while consuming Niranib areNauseaDecreased platelet countFatigue (including weakness)HeadacheDecreased appetiteNasopharyngitisAnemia (low red blood cell count)ConstipationVomitingDecreased neutrophil count DizzinessHeartburnBack painLow total white blood cell count
Before starting on Niranib it is advisable to inform your doctor regarding any other medications you may be taking. It is advisable to not take any vaccinations when on Niranib.
This product is certified and registered with Directorate General of Drug Administration (DGDA) , Ministry of Health & Family Welfare, Government of the People's republic of Bangladesh.